-
Working in Rare Diseases: A Business Model
Suzanne Elvidge
February 28, 2025
This study by Wang Xugao's team reveals how forest tree species stably co - exist in different latitudes through spatial strategies, opening up new directions for understanding forest ecosystem diversity.
-
Single catalyst could simplify biomanufacturing, lowering costs
europeanpharmaceuticalreview
March 11, 2020
Chemists have synthesised a single catalyst, able to perform multistep cascades of chemical reactions to produce a pharmaceutical product.
-
Medical Bookkeeping Costs U.S. $812 Billion a Year
drugs
January 07, 2020
Medical paperwork cost the United States $812 billion in 2017 and accounted for more than one-third of total spending for doctor visits, hospitals, long-term care and health insurance, according to a new study.
-
House Speaker Unveils Plan to Lower Drug Costs
drugs
September 20, 2019
House Speaker Nancy Pelosi has revealed a plan to lower the cost of medications for people on Medicare and those with private insurance.
-
Costs of Reusable Colonoscopes Vary Based on Center Volume
drugs
September 02, 2019
The cost per colonoscopy, including purchase, maintenance, and reprocessing costs, varies from $188.64 to $501.16, with higher costs at low-volume centers...
-
Cost Burden of Disease Progression High in Multiple Myeloma
drugs
August 16, 2019
The economic burden of disease progression is considerable among multiple myeloma (MM) patients receiving drug therapy across all lines of therapy (LOTs)...
-
Senate Bill Would Reduce Drug Costs for Seniors
drugs
July 24, 2019
A bill to reduce prescription drug costs for millions of Medicare recipients and lower federal and state health costs has been introduced by two U.S. senators.
-
Though 'Donut Hole' Is Shrinking, Medicare Drug Costs Are Rising: Study
drugs
May 29, 2019
Though 'Donut Hole' Is Shrinking, Medicare Drug Costs Are Rising.
-
Rising Rx Drug Costs Continue to Create Tough Choices for Seniors
drugs
May 23, 2019
A solid minority of senior citizens still struggles to afford their prescription medications, a new government report shows.
-
Amgen and Astellas Pharma US agree to settlement costs for kickback charges
europeanpharmaceuticalreview
May 05, 2019
Amgen and Astellas Pharma US have agreed to pay a total of $124.75 million to settle allegations that they paid kickbacks to Medicare copays for their own medications.